ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links2 made here, not in the record6 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07894328A Phase III Clinical Studyof HRS-6209 Plus Letrozoleas First-line Therapy inPatients With Advanced orMetastatic Breast CancerJiangsu HengRui Medicine Co., Phase 3 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Version of 2026-10-26CONDITIONSBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionDRUGSHRS-6209Entry “HRS-6209 + Letrozole”, read by…›Nov 18 · Rule based · TestedTestedLetrozoleEntry “HRS-6209 + Letrozole”, read by…›Nov 18 · Rule based · TestedTestedPalbociclibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ComparatorComparatorAnastrozoleMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Palbociclib

Made here1 judgment on this link
NCT07894328gives it, found by reading the recordPalbociclibDefined by Claude Opus 5.5Nov 3, 2026, 7:57 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Nov 3Palbociclibmade hereClaude Opus 5.5ComparatorCurrent
Nov 10Anastrozolemade hereClaude Opus 5.5ComparatorCurrent
Nov 14Breast NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 18HRS-6209Rule based · role ruleTestedCurrent
Nov 18LetrozoleRule based · role ruleTestedCurrent
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.